Back to Search
Start Over
Reduced Incidence and Better Liver Disease Outcomes among Chronic HCV Infected Patients Who Consume Cannabis
- Source :
- Canadian Journal of Gastroenterology and Hepatology, Vol 2018 (2018), Canadian Journal of Gastroenterology & Hepatology
- Publication Year :
- 2018
- Publisher :
- Hindawi Limited, 2018.
-
Abstract
- Background and Aim. The effect of cannabis use on chronic liver disease (CLD) from Hepatitis C Virus (HCV) infection, the most common cause of CLD, has been controversial. Here, we investigated the impact of cannabis use on the prevalence of CLD among HCV infected individuals. Methods. We analyzed hospital discharge records of adults (age ≥ 18 years) with a positive HCV diagnosis. We evaluated records from 2007 to 2014 of the Nationwide Inpatient Sample (NIS). We excluded records with other causes of chronic liver diseases (alcohol, hemochromatosis, NAFLD, PBC, HBV, etc.). Of the 188,333 records, we matched cannabis users to nonusers on 1:1 ratio (4,728:4,728), using a propensity-based matching system, with a stringent algorithm. We then used conditional regression models with generalized estimating equations to measure the adjusted prevalence rate ratio (aPRR) for having liver cirrhosis (and its complications), carcinoma, mortality, discharge disposition, and the adjusted mean ratio (aMR) of total hospital cost and length of stay (LOS) [SAS 9.4]. Results. Our study revealed that cannabis users (CUs) had decreased prevalence of liver cirrhosis (aPRR: 0.81[0.72-0.91]), unfavorable discharge disposition (0.87[0.78-0.96]), and lower total health care cost ($39,642[36,220-43,387] versus $45,566[$42,244-$49,150]), compared to noncannabis users (NCUs). However, there was no difference among CUs and NCUs on the incidence of liver carcinoma (0.79[0.55-1.13]), in-hospital mortality (0.84[0.60-1.17]), and LOS (5.58[5.10-6.09] versus 5.66[5.25-6.01]). Among CUs, dependent cannabis use was associated with lower prevalence of liver cirrhosis, compared to nondependent use (0.62[0.41-0.93]). Conclusions. Our findings suggest that cannabis use is associated with decreased incidence of liver cirrhosis, but no change in mortality nor LOS among HCV patients. These novel observations warrant further molecular mechanistic studies.
- Subjects :
- Adult
Liver Cirrhosis
Male
medicine.medical_specialty
Marijuana Abuse
Cirrhosis
Carcinoma, Hepatocellular
Article Subject
Prevalence
Chronic liver disease
03 medical and health sciences
Liver disease
0302 clinical medicine
Internal medicine
medicine
Humans
Hospital Mortality
Hospital Costs
lcsh:RC799-869
Propensity Score
Aged
Hepatology
biology
business.industry
Incidence (epidemiology)
Incidence
Liver Neoplasms
Gastroenterology
General Medicine
Hepatitis C
Hepatitis C, Chronic
Length of Stay
Middle Aged
biology.organism_classification
medicine.disease
Patient Discharge
United States
030220 oncology & carcinogenesis
Propensity score matching
030211 gastroenterology & hepatology
Female
lcsh:Diseases of the digestive system. Gastroenterology
Cannabis
business
Research Article
Subjects
Details
- Language :
- English
- ISSN :
- 22912797 and 22912789
- Volume :
- 2018
- Database :
- OpenAIRE
- Journal :
- Canadian Journal of Gastroenterology and Hepatology
- Accession number :
- edsair.doi.dedup.....9a95df80b8caeabab26454bab2cfc007